Faure P, Chittal S, Gorguet B, Caveriviere P, Brousset P, Viraben R, Mazerolles C, Delsol G
Department of Anatomical Pathology, CHU Purpan, Toulouse, France.
Am J Dermatopathol. 1990 Apr;12(2):122-33.
Thirty cases of primary (23 cases) and secondary (seven cases) cutaneous B-cell lymphoma (CBCL) were studied by immunohistochemistry using a selected monoclonal antibody (MoAb) panel on both cryostat and paraffin sections. On cryostat sections all CBCL so tested were positive for surface membrane immunoglobulins (IgMk most often) and B-cell antigens (CD22+, CD37+) with a variable T-cell-reactive component identified by MoAbs against T-cell antigens (CD2, CD3, CD4, CD5, CD8). CD4-positive stromal T-cells were usually more numerous than CD8-positive cells. A strong (50-75% of total cells) stromal T-cell (CD2+, CD3+) reaction was found in centroblastic-centrocytic lymphoma. Small numbers of CD1+ Langerhans cells were found in most cases, but they were present in large numbers in follicular lymphoma. On paraffin sections, a combination of MoAbs against B-associated antigens (LN-1, MB2) identified B-cell lineage in virtually all cases of CBCL. CBCL was negative for MoAbs against T-associated antigens (MT1, UCHL1) with rare exceptions (two cases). However, MT1 and UCHL1 combined identified the T-cell nature of all cases of nonepidermotropic, nonmycosis T-cell lymphoma, which were initially predictive of B-lineage by histologic pattern.
采用一组选定的单克隆抗体(MoAb),通过免疫组织化学方法,在冰冻切片和石蜡切片上对30例原发性(23例)和继发性(7例)皮肤B细胞淋巴瘤(CBCL)进行了研究。在冰冻切片上,所有检测的CBCL均对表面膜免疫球蛋白(最常见的是IgMκ)和B细胞抗原(CD22 +、CD37 +)呈阳性,同时通过针对T细胞抗原(CD2、CD3、CD4、CD5、CD8)的MoAb鉴定出可变的T细胞反应成分。CD4阳性的基质T细胞通常比CD8阳性细胞数量更多。在中心母细胞-中心细胞淋巴瘤中发现强烈的(占总细胞的50 - 75%)基质T细胞(CD2 +、CD3 +)反应。在大多数病例中发现少量CD1 +朗格汉斯细胞,但在滤泡性淋巴瘤中数量较多。在石蜡切片上,针对B相关抗原(LN-1、MB2)的MoAb组合在几乎所有CBCL病例中都能鉴定出B细胞谱系。CBCL对针对T相关抗原(MT1、UCHL1)的MoAb呈阴性,仅有罕见例外(2例)。然而,MT1和UCHL1联合使用能鉴定出所有非亲表皮性、非蕈样T细胞淋巴瘤病例的T细胞性质,这些病例最初通过组织学模式被预测为B谱系。